Moderna flu vaccine OK’d by FDA panel (opens in new tab)

WASHINGTON -- A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ending the COVID-19 pandemic.